OraSure Technologies Joins With Actress/Model Dayana Mendoza and the Latino Commission on AIDS to Promote the OraQuick(R) In-Ho
15 10월 2012 - 7:00PM
OraQuick® In-Home HIV Test Now Available in
Retail Stores Nationwide
Press Conference at New York City Hall Monday,
October 15 @ 10:00 AM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that it
will join with actress/model and former Miss Universe Dayana
Mendoza and the Latino Commission on AIDS to promote the OraQuick®
In-Home HIV test and the importance of knowing your HIV status for
National Latino AIDS Awareness Day, taking place on October 15,
2012.
National Latino AIDS Awareness Day (NLAAD) is a national
community mobilization campaign that was established in 2003 by the
Latino Commission on AIDS in response to the devastating impact of
HIV and AIDS on Hispanic/Latino communities nationwide. NLAAD
unites the diverse Hispanic/Latino community in an effort to raise
HIV awareness and promote HIV testing, prevention and
education.
OraSure recently announced the launch of its OraQuick® In-Home
HIV Test, the first rapid infectious disease test ever to be made
available directly to consumers for in-home use. As part of the
launch, the Company is addressing a major public health need by
collaborating with Ms. Mendoza, as well as other celebrities, in an
ongoing educational campaign on the importance of knowing your HIV
status.
"HIV/AIDS is a significant health threat to Hispanic/Latino
communities in the United States," said Ms. Mendoza. "Knowing your
status is the best thing, no matter who you are. The good news is
that there's now a new way to learn your status and help prevent
the spread of HIV. The FDA recently approved OraQuick, the first
in-home oral rapid HIV test. OraQuick allows you to test for HIV in
the comfort and privacy of your home, with results in just 20
minutes."
"The new OraQuick® In-Home HIV Test is a critical new tool in
addressing the impact of HIV/AIDS in our communities," said
Guillermo Chacón, President of the Latino Commission on AIDS. "This
test will help to reduce stigma and fill an unmet need by providing
an additional testing option for individuals who otherwise might
not get tested."
"We are honored to be working with Ms. Dayana Mendoza, the
Latino Commission on AIDS, and so many dedicated state and local
organizations to raise awareness of the importance of HIV testing
on National Latino AIDS Awareness Day," said Douglas A. Michels,
President and Chief Executive Officer of OraSure Technologies. "Now
for the first time ever, individuals have access to the OraQuick
In-Home HIV test – the same test healthcare professionals have used
and trusted for years – that will empower them to learn their HIV
status in the comfort and privacy of their own homes."
Despite testing options that have been available for years, the
Centers for Disease Control and Prevention (CDC) estimate that
approximately 1.2 million people in the U.S. have HIV and
approximately 240,000 of them are unaware of their status. Those
who do not know they are HIV positive are disproportionately
responsible for a majority of the 50,000 new HIV infections that
occur each year. The CDC recommends routine HIV screening for all
people ages 13 to 64, with more frequent testing for people at
higher risk.
The OraQuick® In-Home HIV Test detects antibodies to both HIV-1
and HIV-2 with an oral swab, providing a confidential in-home
testing option with results in as little as 20 minutes. The in-home
test is an over-the-counter version of OraQuick ADVANCE®, an oral
swab rapid test with more than 25 million units sold in the
professional market, including doctors, hospitals, clinics and
other trained professionals. The OraQuick In-Home HIV Test is now
available in retail stores nationwide, through select retailers
online and at OraQuick.com.
NLAAD Press Conference Information:
In recognition of National Latino AIDS Awareness Day, The Latino
Commission on AIDS will hold a press conference on Monday, October
15th at 10:00 AM on the steps of New York City
Hall.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of oral fluid diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
testing solutions for detecting various drugs of abuse. In July
2012, the Company received approval from the U.S. Food and Drug
Administration for the Company's OraQuick® In-Home HIV Test for
sale directly to consumers in the over-the-counter (OTC) market –
making it the first and only rapid OTC HIV test approved in the
U.S. In addition, the Company is a leading provider of oral fluid
sample collection, stabilization and preparation products for
molecular diagnostic applications. OraSure's portfolio of products
is sold globally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. The Company's products enable healthcare
providers to deliver critical information to patients, empowering
them to make decisions to improve and protect their
health.
For more information on OraSure Technologies, please visit
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: Media Contact:
Jennifer Moritz
Zer0 to 5ive for OraSure Technologies
917-748-4006
jmoritz@0to5.com
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024